Back to Woodline Partners LP Woodline Partners LP

SNDXSNDX
Showing 8 of 21 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in SYNDAX PHARMACEUTICALS INC

Yes. Woodline Partners holds 1,250,760 shares of SNDX (Syndax Pharmaceuticals), worth $27.3M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Woodline Partners has held SNDX since Q2 2023, across 13 quarterly 13F filings. SNDX is 0.1% of Woodline Partners' reported 13F portfolio.

Current Value

$27.3M

Current Shares

1.3M

Total Value Change

-$9.2M

Total Shares Change

-645,272

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
1.3M
0.0%
$27.3M0.1%$21.86
0
2026-Q1
Increased
1.3M
+0.0%
$29.2M0.1%$21.40
34
2025-Q4
Decreased
1.3M
-19.3%
$26.3M0.1%$20.74
0
2025-Q3
Decreased
1.6M
-18.1%
$23.9M0.1%$15.56
0
2025-Q2
Increased
1.9M
+0.1%
$17.7M0.1%$9.04
28
2025-Q1
Unchanged
1.9M
0.0%
$23.2M0.2%$13.18
0
2024-Q4
Decreased
1.9M
-0.2%
$25M0.2%$12.52
0
2024-Q3
Increased
1.9M
+22.7%
$36.5M0.3%$18.89
42

Other major holders of SNDX: WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used